自引率: 3.2%
被引量: 7689
通过率: 暂无数据
审稿周期: 6
版面费用: 暂无数据
国人发稿量: 16
投稿须知/期刊简介:
Clinical Therapeutics provides a rapid publication of original reports of recent developments in drug therapy. The journal serves an international audience of research clinicians in academia and industry by quickly disseminating their findings through major biomedical databases.The journal features three sections: Clinical Studies, Review Articles, and Pharmaceutical Economics & Health Policy. Published articles range from pilot studies, which explore new drugs and existing drugs for applications, to large multicenter Phase III and IV trials and postmarketing studies. Audience: Research Clinicians in Academia and Industry, Practicing Physicians, Pharmacologists, and Specialists in Pharmacoeconomics, Outcomes Research and Health Policy.
期刊描述简介:
Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases. Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolerability in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability, and biosimilarity; and changes in practice guidelines and standards, are all of interestfor publication. Clinical Therapeutics also understands the importance of strengthening the body of evidencesurrounding particular agents through the publication of replication studies, negative trials, and failed trials. Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process. In addition to feature articles published monthly, each issue of Clinical Therapeutics features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. 2019 TOPIC UPDATE CALENDAR Submit your manuscript at http://www.ees.elsevier.com/clinther
-
Xolremdi-Mavorixafor.
被引量:- 发表:1970
-
Comment on "Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials".
被引量:- 发表:1970
-
The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab.
被引量:- 发表:1970
-
Association Between Prior Antiplatelet Therapy and Prognosis in Patients With Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis.
被引量:- 发表:1970
-
Bariatric Surgery Underutilization in Young Postadolescent Population With Obesity.
Bariatric surgery is an established treatment option for adolescent patients struggling with obesity, yet it remains underutilized. We aimed to gain insight into patients' views of bariatric surgery and identify the strategies for improved utilization of the procedure in early postadolescence. The electronic medical records of patients diagnosed with obesity at a tertiary medical center, ages 18-22 years old, were examined. Patients participated in a follow-up survey related to obesity treatment. While 20% of patients had BMIs ≥ 35 kg/m2 in adolescence, more than half (54%) of patients with obesity reached BMIs ≥ 35 kg/m2 after 18 y/o, thus potentially qualifying for bariatric surgery. A minority of patients (6/280, 2%) underwent bariatric surgery and experienced substantial weight loss in early postadolescence. Most remaining surgery-eligible patients (141/152, 93%) noted a BMI increase (0.05-28.6 kg/m2) during the immediate young adult study period without surgical intervention. While 66.7% of patients who recall receiving surgery-specific counseling would consider surgery as a part of their treatment, only 4.6% of patients who did not recall counseling would consider undergoing bariatric surgery. In the absence of provider referral during adolescence, bariatric surgery remains underutilized in early postadolescence. Provider counseling is an essential component of patients' willingness to consider bariatric surgery.
被引量:- 发表:1970